Literature DB >> 2950730

Pharmacokinetics of L-dopa in patients with Parkinson's disease.

M A Mena, V Muradas, E Bazan, J Reiriz, J G de Yebenes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2950730

Source DB:  PubMed          Journal:  Adv Neurol        ISSN： 0091-3952


× No keyword cloud information.
  8 in total

1.  The effect of benserazide on the peripheral and central distribution and metabolism of levodopa after acute and chronic administration in the rat.

Authors:  A P Kent; G M Stern; R A Webster
Journal:  Br J Pharmacol       Date:  1990-08       Impact factor: 8.739

2.  The effects of L-dopa on the activity of methionine adenosyltransferase: relevance to L-dopa therapy and tolerance.

Authors:  R Benson; B Crowell; B Hill; K Doonquah; C Charlton
Journal:  Neurochem Res       Date:  1993-03       Impact factor: 3.996

3.  The role of 3-O-methyldopa in the side effects of L-dopa.

Authors:  Eun-Sook Y Lee; Hongtao Chen; Jennifer King; Clivel Charlton
Journal:  Neurochem Res       Date:  2007-08-24       Impact factor: 3.996

Review 4.  Concentration-effect relationship of levodopa in patients with Parkinson's disease.

Authors:  S Harder; H Baas; S Rietbrock
Journal:  Clin Pharmacokinet       Date:  1995-10       Impact factor: 6.447

5.  The COMT inhibitor tolcapone potentiates the anticataleptic effect of Madopar in MPP(+)-lesioned mice.

Authors:  N Himori; K Mishima
Journal:  Experientia       Date:  1994-10-15

6.  Low catechol-O-methyltransferase activity in a Saami population.

Authors:  B Klemetsdal; B Straume; T Giverhaug; J Aarbakke
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

7.  Substantia nigra degeneration and tyrosine hydroxylase depletion caused by excess S-adenosylmethionine in the rat brain. Support for an excess methylation hypothesis for parkinsonism.

Authors:  C G Charlton; J Mack
Journal:  Mol Neurobiol       Date:  1994 Aug-Dec       Impact factor: 5.590

8.  Impact of the catechol-O-methyltransferase Val158Met polymorphism on the pharmacokinetics of L-dopa and its metabolite 3-O-methyldopa in combination with entacapone.

Authors:  Joe Yamamoto; Tomohiro Omura; Sachiko Kasamo; Shota Yamamoto; Masayoshi Kawata; Atsushi Yonezawa; Yosuke Taruno; Hisako Endo; Hitoshi Aizawa; Nobukatsu Sawamoto; Kazuo Matsubara; Ryosuke Takahashi; Yoshikazu Tasaki
Journal:  J Neural Transm (Vienna)       Date:  2020-11-02       Impact factor: 3.575
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.